OS Therapies OSTX
NYSE OSTX
$1.59 +0.01 (+0.63%)
At close: Aug 21, 2026 · 4:00 PM EDT

OS Therapies (OSTX) EPS (Basic) (2023 - 2026)

OS Therapies' (OSTX) quarterly EPS (Basic) came in at -$0.82 in Q1 2026, down 163.28% YoY from $1.3 in Q1 2025, and up 36.79% on a QoQ basis from -$1.3 in Q4 2025.

OS Therapies (OSTX) EPS (Basic) (2023 - 2026) Analysis & Trends

OS Therapies (OSTX) has 4 years of EPS (Basic) data on file, last reported at -$0.82 in Q1 2026.

  • Quarterly EPS (Basic) fell 163.28% year-over-year to -$0.82 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.8 (down 206.44% YoY) and the FY2025 annual result came in at -$2.79, down 286.97% from the prior year.
  • EPS (Basic) grew to -$0.82 in Q1 2026, from -$1.3 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.18 in Q3 2024 to a low of -$3.87 in Q3 2025.
  • A 4-year average of -$0.75 and a median of -$0.37 in 2023 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2024 — EPS (Basic) surged 51.86% — and 2025, when it sank 2042.06%.
  • Tracing OSTX's EPS (Basic) over 4 years: stood at -$0.28 in 2023, then increased by 12.28% to -$0.24 in 2024, then tumbled by 439.86% to -$1.3 in 2025, then soared by 36.79% to -$0.82 in 2026.
  • The last three EPS (Basic) figures came in at -$0.82 (Q1 2026), -$1.3 (Q4 2025), and -$3.87 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.62
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 7.59
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.23
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -0.72
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.18
10 OS Therapies 19.46 Mn 19.46 Mn - -0.70

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.82
Dec 31, 2025 -1.30
Sep 30, 2025 -3.87
Jun 30, 2025 -0.95
Mar 31, 2025 -0.31
Dec 31, 2024 -0.24
Sep 30, 2024 -0.18
Jun 30, 2024 -0.26
Mar 31, 2024 -0.26
Dec 31, 2023 -0.28
Sep 30, 2023 -0.38
Jun 30, 2023 -0.47
Mar 31, 2023 -0.37